MedPath
FDA Approval

Terconazole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Bryant Ranch Prepack
DUNS: 171714327
Effective Date
January 15, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Terconazole(8 mg in 1 g)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Bryant Ranch Prepack

171714327

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Bryant Ranch Prepack

Bryant Ranch Prepack

Bryant Ranch Prepack

171714327

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Terconazole Vaginal Cream 0.8%

Product Details

NDC Product Code
63629-8837
Application Number
NDA021735
Marketing Category
NDA (C73594)
Route of Administration
VAGINAL
Effective Date
September 15, 2021
Code: 0KJ2VE664UClass: ACTIBQuantity: 8 mg in 1 g
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4MClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
CETYL ALCOHOLInactive
Code: 936JST6JCNClass: IACT
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
STEARYL ALCOHOLInactive
Code: 2KR89I4H1YClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath